Prevention of Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation)

Affiliations

¹ Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: rihal@mayo.edu.
² Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Free article

Editorial

Charanjit S Rihal et al. JACC Cardiovasc Interv. 2015 Oct.

Free article

. 2015 Oct;8(12):1605-7.

doi: 10.1016/j.jcin.2015.08.007.

¹ Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: rihal@mayo.edu.
² Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

No abstract available

Keywords: TAVR; acute kidney injury; contrast nephropathy.

Comment on

Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
Barbanti M, Gulino S, Capranzano P, Immè S, Sgroi C, Tamburino C, Ohno Y, Attizzani GF, Patanè M, Sicuso R, Pilato G, Di Landro A, Todaro D, Di Simone E, Picci A, Giannetto G, Costa G, Deste W, Giannazzo D, Grasso C, Capodanno D, Tamburino C. Barbanti M, et al. JACC Cardiovasc Interv. 2015 Oct;8(12):1595-604. doi: 10.1016/j.jcin.2015.07.012. Epub 2015 Sep 17. JACC Cardiovasc Interv. 2015. PMID: 26386766 Clinical Trial.